glp-1 agonist cost Infographic: GLP 1 Adherence and Impact for Plans glp 1 how much does

The smartest strategy is to act now

Setmelanotide is FDA approved for ages 6 years and older to treat monogenic obesity due to variants that are pathogenic, likely pathogenic or variant of unknown significance (VUS) in POMC (pro opiomelanocortin), PCSK1 (proprotein convertase subtilisin/kexin type 1), LEPR (leptin receptor) and Bardet Biedl Syndrome (BBS)

launch comes as competition in the GLP-1 space intensifies

Iwaya, C., Nomiyama, T., Komatsu, S., Kawanami, T., Tsutsumi, Y., Hamaguchi, Y., Horikawa, T., Yoshinaga, Y., Yamashita, S., Tanaka, T., et al

Medical experts strongly advise postponing GLP-1 therapy, such as semaglutide or liraglutide, until nursing has stopped

However, much more research is needed to fully answer this question